RS
LUNG icon

R Squared’s Pulmonx LUNG Stock Holding History

R Squared’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.7K Buy
27,429
+7,649
+39% +$10.5K 0.02% 464
2026
Q1 		$25.5K Buy
+19,780
New +$32.7K 0.01% 453
2025
Q4 		– Sell
-14,683
Closed -$23.8K – 636
2025
Q3 		$23.8K Sell
14,683
-1,328
-8% -$2.78K 0.01% 524
2025
Q2 		$41.5K Buy
+16,011
New +$63.2K 0.02% 404
2025
Q1 		– Sell
-6,763
Closed -$45.9K – 964
2024
Q4 		$45.9K Buy
+6,763
New +$44.5K 0.04% 526

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

R Squared's LUNG Position: Q2 2026 in Review

R Squared increased its Pulmonx (LUNG) stake by 39% in Q2 2026, buying an estimated $10.5K and bringing the position to 27,429 shares worth $35.7K. The position accounts for 0.02% of the portfolio, ranked #464.

R Squared first reported a position in LUNG in Q4 2024 and has held it in 5 quarters since. The position peaked at $45.9K in Q4 2024. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • R Squared held 27,429 shares of Pulmonx worth $35.7K as of Q2 2026.
  • R Squared bought 7,649 Pulmonx shares in Q2 2026, an estimated $10.5K.
  • Pulmonx made up 0.02% of R Squared's portfolio in Q2 2026, its #464 holding.
  • R Squared first reported a position in Pulmonx in Q4 2024 and has held it in 5 quarters since.
  • R Squared's Pulmonx position peaked at $45.9K in Q4 2024.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.